Company: IMG
Filing Date: 2025-02-13
Form Type: PRE 14C
Source: 0001493152-25-006428
Chunk: 2

Company: CIMG Inc.
Filing Date: 2025-02-13
Form: PRE 14C
Chunk 2
---
 THE ACTIONS DESCRIBED IN THIS INFORMATION STATEMENT.

<div align='center'>INTRODUCTION</div>

This Information Statement is being mailed or otherwise furnished to the holders of common stock, $0.00001 par value per share (the “Common Stock”) of CIMG Inc., a Nevada corporation (the “Company”), by the Board of Directors (the “Board”) to notify them about certain action the holders of a majority of the voting power of the Company’s outstanding voting securities have taken by written consent in lieu of a shareholders’ meeting. The shareholder action was taken on February 10, 2025. Copies of this Information Statement are first being sent on or about ________________, 2025, to the holders of record as of February 10, 2025, of the outstanding shares of the Company’s common stock.

General Information

Unless otherwise noted, references to the “Company,” “we,” “us,” or “our” mean CIMG Inc., a Nevada corporation. Our principal executive offices are located at 6107, 6th Floor, Building C4, No.1 Huangchang West Road, Dougezhuang, Chaoyang District, Beijing, telephone + 86 18518579917.

By written consent dated February 10, 2025, as permitted by Section 78.320 of the NRS and Section 1.11 of Article I of our bylaws, the stockholders who have the authority to vote a majority of the outstanding shares of common stock, being DYT INFO PTE. LTD, DADA Business Trading Co., Limited, METAVERSE INTELLIGENCE TECH LTD, Xiang Zhang, Xiangrong Dai and Min Li, who together have an aggregate beneficial interest of greater than the majority of our issued and outstanding shares of common stock, approved the following corporate actions (collectively, the “Authorizations”):

| (i) | for                                                                                                                                      
 purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of more than 20% of the Company’s issued and outstanding            
 common stock pursuant to the conversion of notes and exercise of warrants sold under the convertible note and warrant purchase agreement 
 dated December 12, 2024 to raise an aggregate of $10,000,000 with certain investors (the “Purchase Agreement”).                          |

Nasdaq Requirements

The foregoing resolutions for the Purchase Agreement are required because under the terms of the Purchase Agreement, the Company will have to issue up to 20,576,923 shares